Vista simple de metadatos

dc.contributorElsevieres_CL
dc.contributor.authorAguilera, Sergio [Chile. Clínica INDISA]es_CL
dc.contributor.authorCastro, Isabel [Universidad de Chile]es_CL
dc.contributor.authorCortés, Juan [Universidad de Chile]es_CL
dc.contributor.authorGonzález,Sergio [Chile. Universidad Mayor]es_CL
dc.date.accessioned2018-09-07T14:11:44Z
dc.date.available2018-09-07T14:11:44Z
dc.date.issued2016es_CL
dc.identifier.citationBarrera, M. J., Aguilera, S., Castro, I., Cortés, J., Bahamondes, V., Quest, A. F., ... & Leyton, C. (2016). Pro-inflammatory cytokines enhance ERAD and ATF6α pathway activity in salivary glands of Sjögren's syndrome patients. Journal of autoimmunity, 75, 68-81.es_CL
dc.identifier.issnISSN 0896-8411es_CL
dc.identifier.urihttps://ac.els-cdn.com/S0896841116301147/1-s2.0-S0896841116301147-main.pdf?_tid=3088c7ba-4718-44bb-adf6-16309e0524d0&acdnat=1535147179_62d6e76e1da4faedcacad74795618fc5es_CL
dc.identifier.urihttps://doi.org/10.1016/j.jaut.2016.07.006es_CL
dc.identifier.urihttp://repositorio.umayor.cl/xmlui/handle/sibum/2762
dc.description.abstractSalivary gland (SG) acinar-cells are susceptible to endoplasmic reticulum (ER) stress related to their secretory activity and the complexity of synthesized secretory products. SGs of Sjögren's syndrome patients (SS)-patients show signs of inflammation and altered proteostasis, associated with low IRE1α/XBP-1 pathway activity without avert increases in apoptosis. Acinar-cells may avoid apoptosis by activation of the ATF6α pathway and ER-associated protein degradation (ERAD). The aim of this study was to evaluate the role of pro-inflammatory cytokines in ATF6α pathway/ERAD activation and cell viability in labial salivary glands (LSG) of SS-patients. In biopsies from SS-patients increased ATF6α signaling pathway activity, as evidenced by generation of the ATF6f cleavage fragment, and increased expression of ERAD machinery components, such as EDEM1, p97, SEL1L, gp78, UBE2J1, UBE2G2, HERP and DERLIN1, were observed compared to controls. Alternatively, for pro- (active-caspase-3) and anti-apoptotic (cIAP2) markers no significant difference between the two experimental groups was detected. Increased presence of ATF6f and ERAD molecules correlated significantly with increased expression of pro-inflammatory cytokines. These observations were corroborated in vitro in 3D-acini treated with TNF-α and/or IFN-γ, where an increase in the expression and activation of the ATF6α sensor and ERAD machinery components was detected under ER stress conditions, while changes in cell viability and caspase-3 activation were not observed. Cytokine stimulation protected cells from death when co-incubated with an ERAD machinery inhibitor. Alternatively, when cytokines were eliminated from the medium prior to ERAD inhibition, cell death increased, suggesting that the presence of pro-inflammatory cytokines in the medium is essential to maintain cell viability. In conclusion, the ATF6α pathway and the ERAD machinery are active in LSG of SS-patients. Both were also activated by TNF-α and IFN-γ in vitro in 3D-acini and aided in preventing apoptosis. IFN-γ levels were elevated in SS-patients and UPR responses triggered in vitro by this cytokine closely matched those observed in LSG from SS-patients, suggesting that cytokines may induce ER stress.es_CL
dc.description.sponsorshipEste trabajo fue financiado por Fondecyt Chile [#1160015 and 1120062] (MJG, SA, CM, SG), PhD fellowship Conicyt-Chile (MJB and JC), CONICYT-FONDAP [#15130011] (AFGQ).es_CL
dc.format.extentARTÍCULO ORIGINALes_CL
dc.language.isoenes_CL
dc.publisherCIENCIASes_CL
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chilees_CL
dc.subjectINMUNOLOGÍAes_CL
dc.titlePro-inflammatory cytokines enhance ERAD and ATF6α pathway activity in salivary glands of Sjögren's syndrome patientses_CL
dc.typeArtículo o Paperes_CL
umayor.indizadorCOTes_CL
umayor.politicas.sherpa/romeoLicencia color: VERDE C/R (Se puede archivar el pre-print y el post-print o versión de editor/PDF, el autor no puede archivar la versión del editor/PDF)--Authors pre-print on any website, including arXiv and RePEC Author's post-print on author's personal website immediately Author's post-print on open access repository after an embargo period of between 12 months and 48 months Permitted deposit due to Funding Body, Institutional and Governmental policy or mandate, may be required to comply with embargo periods of 12 months to 48 months Author's post-print may be used to update arXiv and RepEC La versión de editor/PDF no puede utilizarse Debe enlazar a la versión de editor con DOI Author's post-print must be released with a Creative Commons Attribution Non-Commercial No Derivatives License// Disponible en: http://www.sherpa.ac.uk/romeo/issn/0896-8411/es/es_CL
umayor.indexadoWOSes_CL
umayor.indexadoSCOPUSes_CL
dc.identifier.doi10.1016/j.jaut.2016.07.006es_CL]
umayor.indicadores.wos-(cuartil)Q1es_CL
umayor.indicadores.scopus-(scimago-sjr)sin informaciónes_CL


Vista simple de metadatos



Modificado por: Sistema de Bibliotecas Universidad Mayor - SIBUM
DSpace software copyright © 2002-2018  DuraSpace